Funding · Company
Iambic Therapeutics, Inc.
San Diego, CABiotech & Pharma
Iambic Therapeutics, Inc. of San Diego, CA has disclosed $269M across 4 Form D offerings filed with the SEC between Oct 12, 2023 and Apr 8, 2026.
$269M
Total disclosed
4
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$28M
Form D · Apr 8, 2026 ↗
Q2 2026
· target $50M
$99M
Form D · Nov 21, 2025 ↗
Q4 2025
· target $125M
$38M
Form D · Jun 6, 2024 ↗
Q2 2024
· 2 amendments, first filed Apr 25, 2024
· target $50M
$103M
Form D · Oct 12, 2023 ↗
Q4 2023
· target $110M
Filing details
HeadquartersSan Diego, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001997038Offerings on file4
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →